Literature DB >> 24563118

Commentary: current perspectives on the aggregation of protein drugs.

Elizabeth M Topp1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24563118      PMCID： PMC4012046          DOI： 10.1208/s12248-014-9580-0

Source DB:  PubMed          Journal:  AAPS J        ISSN： 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  11 in total

1.  An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.

Authors:  Mohammad A Alsenaidy; Tingting Wang; Jae Hyun Kim; Sangeeta B Joshi; Jihun Lee; Michael Blaber; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-02-06       Impact factor: 6.725

2.  Aggregation and pH-temperature phase behavior for aggregates of an IgG2 antibody.

Authors:  Erinc Sahin; William F Weiss; Andrew M Kroetsch; Kevin R King; R Kendall Kessler; Tapan K Das; Christopher J Roberts
Journal:  J Pharm Sci       Date:  2012-01-13       Impact factor: 3.534

3.  Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.

Authors:  Weiqiang Cheng; Sangeeta B Joshi; Feng He; David N Brems; Bing He; Bruce A Kerwin; David B Volkin; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2012-02-09       Impact factor: 3.534

4.  Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.

Authors:  Ozan S Kumru; Jun Liu; Junyan A Ji; Wilson Cheng; Y John Wang; Tingting Wang; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2012-06-25       Impact factor: 3.534

5.  Comparability assessments of process and product changes made during development of two different monoclonal antibodies.

Authors:  Anthony Lubiniecki; David B Volkin; Marcia Federici; Michael D Bond; Michael L Nedved; Linda Hendricks; Promod Mehndiratta; Mark Bruner; Sudhir Burman; Paul Dalmonte; Jane Kline; Alex Ni; Mark E Panek; Bill Pikounis; Gordon Powers; Omid Vafa; Rich Siegel
Journal:  Biologicals       Date:  2010-10-14       Impact factor: 1.856

Review 6.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

7.  Silica colloidal crystals as emerging materials for high-throughput protein electrophoresis.

Authors:  Nadine K Njoya; Robert E Birdsall; Mary J Wirth
Journal:  AAPS J       Date:  2013-06-26       Impact factor: 4.009

8.  Slip flow in colloidal crystals for ultraefficient chromatography.

Authors:  Bingchuan Wei; Benjamin J Rogers; Mary J Wirth
Journal:  J Am Chem Soc       Date:  2012-06-22       Impact factor: 15.419

9.  Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life.

Authors:  Christopher J Roberts; Richard T Darrington; Maureen B Whitley
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

Review 10.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009
View more
  1 in total

1.  Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.

Authors:  Lili Wen; Xianxian Zheng; Xinyue Wang; Hairong Lan; Zongning Yin
Journal:  Pharm Res       Date:  2017-04-11       Impact factor: 4.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.